NICE recommends Bayer’s MS treatment, complementary cancer therapies ‘do more harm than good’, Daiichi Sankyo announces results of Phase 3 CLEAR Wisdom trial, and could greater collaboration accelerate much-needed treatments for children with rare diseases?
The NIHR is to invest £34 million into global health research projects within low and middle-income countries, a ‘DIY’ alternative to traditional smear tests is ‘promising’, and the BBC shares 10 charts that show why the NHS does matter in the upcoming UK election.
Many of us recognise intellectually that we need others’ knowledge to address the opportunities and challenges we face in our day to day jobs in pharma, yet we still lack the time or motivation to collaborate. Engaging with third parties all too often feels inefficient.
Our world is changing. Over the last 15 years, 52% of Fortune 500 companies have disappeared. I often wonder if this trend will impact our sector. While pharma has been relatively isolated from disruptive technologies, the recently intensified pressure on drug pricing from policy makers is really challenging pharma executives.
As technology continues to evolve, different ways to communicate are endless; telephone, email, Skype and social media are integral to work life today.
The UK’s private healthcare market hit £5.6 billion in value in 2015, with providers and commentators reporting annual growth of 15-25%. What are the differences between private healthcare and the NHS?
The NHS has helped millions of people through illness and injury, but how much do we actually know about the organisation? Here are our top 5 interesting NHS facts.
You’ve graduated, looking to break into the commercial world of medical device sales, but don’t know where to start, or maybe you’ve worked in sales and want to test your skills in the challenging medical devices area. A question that keeps cropping up over and over again is often the same: ‘how I get into medical devices sales?’
See the big picture, make better decisions, improve things. This is the mantra of any organisation you care to mention. It’s also true of healthcare: examine huge amounts of data, discover patterns, prevent a potential epidemic.